Invention Grant
- Patent Title: Early treatment of CMT disease
-
Application No.: US16505000Application Date: 2019-07-08
-
Publication No.: US10940147B2Publication Date: 2021-03-09
- Inventor: Daniel Cohen , Ilya Chumakov , Rodolphe Hajj , Aude Milet , Serguei Nabirochkin , Klaus-Armin Nave , Thomas Prukop , Michael Sereda
- Applicant: Pharnext
- Applicant Address: FR Issy les Moulineaux
- Assignee: Pharnext
- Current Assignee: Pharnext
- Current Assignee Address: FR Issy les Moulineaux
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Joseph W. Arico
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61K31/197 ; C12Q1/6883 ; A61K31/047
Abstract:
The present invention provides methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A), by administering to a subject in need thereof a combination comprising baclofen, sorbitol and naltrexone, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20200030314A1 EARLY TREATMENT OF CMT DISEASE Public/Granted day:2020-01-30
Information query
IPC分类:
